Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
4
×
life sciences
liver disease
nash
4
×
national blog main
acelity
acquisition
apax partners
botox
breast implant
breast reconstruction
buyout
chase pharmaceutical corp.
employment
exome
fired
job cut
jobs
joe woody
kci
kinetic concepts
lay off
layoff
leveraged buyout
life science
lifecell
medical device
medical devices
merger
negative-pressure wound healing
neurodegenerative disorder
new hire
non-alcoholic steatohepatitis
plastic surgery
private equity
reconstructive surgery
restructuring
rhythm pharmaceuticals
san antonio
surgery
What
acelity
antonio
known
san
company
products
wound
ace
acquired
approved
bandages
billion
business
consortium
cuts
data
deal
decades
disease
drug
ending
equity
eyes
fatty
firms
healing
horizon
initial
intercept
ipo
jobs
kinetic
lay
life
liver
maker
marketed
medicine
nash
nc
Language
Current search:
nash
×
allergan
×
@xconomy.com
5 years ago
Acelity Sells to 3M in Deal Valued at $6.7 Billion, Ending IPO Plan
@xconomy.com
5 years ago
San Antonio Wound-Care Company Eyes (Another) Initial Public Offering
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
San Antonio Life Science Business Acelity Cuts 260 Jobs in Texas, NC